Latest period
$18.25B
YoY change
+10.4%
5Y CAGR
+4.4%
Peak year (2025)
$19.20B
Latest annual
$19.20B
Total Liabilities history chart for Boston Scientific (BSX) from 1991 to 2025
Latest: $19.20B
Total Liabilities growth chart for Boston Scientific (BSX) from 1991 to 2025
Latest: +10.4%
Total Liabilities history table for Boston Scientific (BSX) from 1991 to 2025
| 2025 | $19.20B | +10.4% | +$1.81B | ||
| 2024 | $17.39B | +11.4% | +$1.79B | ||
| 2023 | $15.61B | +4.8% | +$710.00M | ||
| 2022 | $14.90B | -4.6% | −$711.00M | ||
| 2021 | $15.61B | +1.0% | +$156.00M | ||
| 2020 | $15.45B | -7.4% | −$1.24B | ||
| 2019 | $16.69B | +36.0% | +$4.42B | ||
| 2018 | $12.27B | +2.0% | +$243.00M | ||
| 2017 | $12.03B | +5.9% | +$667.00M | ||
| 2016 | $11.36B | -3.8% | −$450.00M | ||
| 2015 | $11.81B | +18.3% | +$1.83B | ||
| 2014 | $9.99B | -2.0% | −$208.00M | ||
| 2013 | $10.20B | -0.9% | −$89.00M | ||
| 2012 | $10.28B | +3.5% | +$347.00M | ||
| 2011 | $9.94B | -8.3% | −$895.00M | ||
| 2010 | $10.83B | -15.9% | −$2.04B | ||
| 2009 | $12.88B | -7.6% | −$1.07B | ||
| 2008 | $13.94B | -13.4% | −$2.16B | ||
| 2007 | $16.10B | +1.9% | +$302.00M | ||
| 2006 | $15.80B | +303.6% | +$11.88B | ||
| 2005 | $3.91B | -5.6% | −$231.00M | ||
| 2004 | $4.14B | +46.1% | +$1.31B | ||
| 2003 | $2.84B | +43.1% | +$854.00M | ||
| 2002 | $1.98B | +1.2% | +$24.00M | ||
| 2001 | $1.96B | +31.3% | +$467.00M | ||
| 2000 | $1.49B | -19.3% | −$356.00M | ||
| 1999 | $1.85B | -39.8% | −$1.22B | ||
| 1998 | $3.07B | +212.9% | +$2.09B | ||
| 1997 | $981.60M | +64.8% | +$385.80M | ||
| 1996 | $595.80M | +85.0% | +$273.80M | ||
| 1995 | $322.00M | +250.8% | +$230.20M | ||
| 1994 | $91.80M | +20.0% | +$15.30M | ||
| 1993 | $76.50M | +53.0% | +$26.50M | ||
| 1992 | $50.00M | +6.2% | +$2.90M | ||
| 1991 | $47.10M | — | — |
- 2025$19.20B+10.4%
- 2024$17.39B+11.4%
- 2023$15.61B+4.8%
- 2022$14.90B-4.6%
- 2021$15.61B+1.0%
- 2020$15.45B-7.4%
- 2019$16.69B+36.0%
- 2018$12.27B+2.0%
- 2017$12.03B+5.9%
- 2016$11.36B-3.8%
- 2015$11.81B+18.3%
- 2014$9.99B-2.0%
- 2013$10.20B-0.9%
- 2012$10.28B+3.5%
- 2011$9.94B-8.3%
- 2010$10.83B-15.9%
- 2009$12.88B-7.6%
- 2008$13.94B-13.4%
- 2007$16.10B+1.9%
- 2006$15.80B+303.6%
- 2005$3.91B-5.6%
- 2004$4.14B+46.1%
- 2003$2.84B+43.1%
- 2002$1.98B+1.2%
- 2001$1.96B+31.3%
- 2000$1.49B-19.3%
- 1999$1.85B-39.8%
- 1998$3.07B+212.9%
- 1997$981.60M+64.8%
- 1996$595.80M+85.0%
- 1995$322.00M+250.8%
- 1994$91.80M+20.0%
- 1993$76.50M+53.0%
- 1992$50.00M+6.2%
- 1991$47.10M—
Total Liabilities values are taken from Boston Scientific's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's latest reported total liabilities is $18.25B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Boston Scientific (BSX) most recent annual total liabilities stands at $19.20B (2025) – grew 10.4% year-over-year.
Boston Scientific total liabilities compound annual growth for the 2020–2025 (5 years) window is +4.4%, with mixed annual results across the window.
The highest annual total liabilities of $19.20B was reported in 2025. The lowest in the available history was $47.10M in 1991.
Boston Scientific Total Liabilities by Year
Boston Scientific Total Liabilities 2025: $19.20B
2025's total liabilities for Boston Scientific came in at $19.20B, grew 10.4% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Total Liabilities 2024: $17.39B
Boston Scientific posted total liabilities of $17.39B in 2024, grew 11.4% from 2023.
Boston Scientific Total Liabilities 2023: $15.61B
In 2023, Boston Scientific reported total liabilities of $15.61B, edged up 4.8% from 2022.
Boston Scientific Total Liabilities 2022: $14.90B
Boston Scientific total liabilities in 2022 was $14.90B, edged down 4.6% below 2021.
Boston Scientific Total Liabilities 2021: $15.61B
Boston Scientific total liabilities in 2021 was $15.61B.
See more financial history for Boston Scientific (BSX).
Sector peers by Total Liabilities
Healthcare peers of Boston Scientific (BSX), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation